Study finds link between obesity and vascular dementia
Fox Information senior medical analyst Dr. Marc Siegel joins ‘America’s Newsroom’ to debate a rise of colon most cancers in individuals below 50 regardless of general reducing most cancers deaths and a brand new examine linking weight problems to vascular dementia.
NEWNow you can hearken to Fox Information articles!
A brand new blood take a look at may decide a woman’s dementia risk as early as 25 years earlier than signs emerge.
That’s in keeping with new analysis from the College of California San Diego, which discovered {that a} particular biomarker protein related to early pathological processes of Alzheimer’s illness was “strongly linked” to future dementia threat.
The researchers analyzed blood samples from 2,766 members within the Girls’s Well being Initiative Reminiscence Research within the late Nineteen Nineties, in keeping with the examine’s press launch.
KEY FITNESS MEASURE IS STRONG PREDICTOR OF LONGEVITY AFTER CERTAIN AGE, STUDY FINDS
The ladies ranged from 65 to 79 years of age and confirmed no indicators of cognitive decline at the beginning of the examine.
After monitoring the members for as much as 25 years, the researchers concluded that the biomarker phosphorylated tau 217 (p-tau217) was “strongly related” with future gentle cognitive impairment and dementia.

A brand new blood take a look at may decide a girl’s dementia threat as early as 25 years earlier than signs emerge. (iStock)
Girls who had larger ranges of p-tau217 firstly of the examine have been “more likely” to develop the illness. The findings have been revealed at the moment in JAMA Community Open.
“The important thing takeaway is that our examine suggests it might be doable to detect threat of dementia twenty years prematurely utilizing a easy blood take a look at in older women,” first writer Aladdin H. Shadyab, PhD, UC San Diego affiliate professor of public well being and drugs, advised Fox Information Digital.
“These biomarkers could assist us determine who’s at biggest threat and develop methods to delay or stop dementia.”
“Our findings present that the blood biomarker p-tau217 may assist determine people at larger threat for dementia lengthy earlier than signs start,” he added.
This lengthy lead time may open the door to earlier prevention strategies and extra focused monitoring, relatively than ready till reminiscence issues are already affecting day by day life, in keeping with Shadyab.

A particular biomarker protein related to early pathological processes of Alzheimer’s illness was “strongly linked” to future dementia threat. (iStock)
“Because the analysis advances, these biomarkers could assist us determine who’s at biggest threat and develop methods to delay or stop dementia,” he mentioned.
This threat relationship wasn’t the identical throughout the board, nevertheless. Girls over 70 with larger p-tau217 ranges had “poorer cognitive outcomes” in comparison with these below 70, as did these with the APOE ε4 gene, which is a recognized threat issue for Alzheimer’s disease.
CLICK HERE TO GET THE FOX NEWS APP
The examine additionally discovered that p-tau217 was a stronger predictor of dementia in ladies who have been randomly assigned to obtain estrogen and progestin hormone remedy in comparison with those that obtained a placebo.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Blood-based biomarkers like p-tau217 are particularly promising as a result of they’re far much less invasive and doubtlessly extra accessible than mind imaging or spinal fluid exams,” mentioned senior writer Linda Okay. McEvoy, PhD, senior investigator at Kaiser Permanente Washington Well being Analysis Institute and professor emeritus on the Herbert Wertheim Faculty of Public Well being, within the launch.

“Blood-based biomarkers like p-tau217 are particularly promising as a result of they’re far much less invasive and doubtlessly extra accessible than mind imaging or spinal fluid exams,” a researcher mentioned. (iStock)
“That is essential for accelerating research into the components that have an effect on the chance of dementia and for evaluating methods which will scale back threat.”
Blood exams for Alzheimer’s illness are nonetheless being studied and should not beneficial for routine screening in individuals with out signs, Shadyab famous.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Extra analysis is required earlier than this method will be thought-about for scientific use previous to cognitive signs.
Future research ought to examine how different components — like genetics, hormone remedy and age-related medical conditions — would possibly work together with plasma p-tau217, the researchers added.
CLICK HERE FOR MORE HEALTH STORIES
“The examine examined solely older ladies, so the findings could not essentially apply to males or youthful populations,” Shadyab famous. “We additionally examined general dementia outcomes relatively than particular subtypes equivalent to Alzheimer’s illness.”
